​

Surgery Partners (SGRY) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

SGRY Stock Forecast

Surgery Partners (SGRY) stock forecast, based on 22 Wall Street analysts, predicts a 12-month average price target of $18.85, with a high of $21.00 and a low of $16.25. This represents a 39.84% increase from the last price of $13.48.

$10 $15 $20 $25 $30 $35 High: $21 Avg: $18.85 Low: $16.25 Last Closed Price: $13.48

SGRY Stock Rating

Surgery Partners stock's rating consensus is Buy, based on 22 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 14 Buy (63.64%), 8 Hold (36.36%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 22 0 8 14 Strong Sell Sell Hold Buy Strong Buy

SGRY Price Target Upside V Benchmarks

TypeNameUpside
StockSurgery Partners39.84%
SectorHealthcare Stocks 15.45%
IndustryMedical Care Facilities Stocks19.55%

Price Target Trends

1M3M12M
# Anlaysts457
Avg Price Target$21.81$21.25$20.89
Last Closing Price$13.48$13.48$13.48
Upside/Downside61.80%57.64%54.97%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Mar, 26183--12
Feb, 26183--12
Jan, 26183--12
Dec, 25183--12
Nov, 25183--12
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Mar 11, 2026US Capital Advisors$21.00$13.5055.56%55.79%
Mar 04, 2026Brian TanquilutJefferies$16.25$14.2713.88%20.55%
Mar 04, 2026Ben HendrixRBC Capital$20.00$14.2240.65%48.37%
Mar 03, 2026Jefferies$30.00$13.41123.71%122.55%
Dec 18, 2025Mizuho Securities$19.00$15.8020.25%40.95%
Nov 21, 2025Barclays$18.00$15.3017.65%33.53%
Nov 17, 2025Mizuho Securities$22.00$15.2044.74%63.20%
Nov 13, 2024Brian TanquilutJefferies$40.00$29.7434.50%196.74%
Nov 13, 2024Andrew MokBarclays$31.00$29.744.24%129.97%
Oct 14, 2024AJ RiceUBS$38.00$30.4624.75%181.90%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Mar 11, 2026UBSBuyBuyhold
Mar 04, 2026JefferiesBuyBuyhold
Mar 04, 2026Cantor FitzgeraldOverweightOverweighthold
Mar 04, 2026RBC CapitalOutperformOutperformhold
Mar 03, 2026BenchmarkBuyBuyhold
Nov 14, 2024Cowen & Co.BuyBuyhold
Nov 13, 2024JefferiesBuyBuyhold
Oct 14, 2024UBSBuyinitialise
Oct 10, 2024KeyBancSector Weightinitialise
Oct 04, 2024RBC CapitalBuyBuyhold

Financial Forecast

EPS Forecast

Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27
Reported$-1.12$-0.59$-0.09$-1.33$-0.61--
Avg Forecast$-0.15$0.11$0.93$0.85$0.96$1.21$1.75
High Forecast$-0.15$0.12$0.96$0.98$1.17$1.35$1.78
Low Forecast$-0.15$0.11$0.89$0.76$0.72$0.95$1.73
Surprise %646.67%-636.36%-109.68%-256.47%-163.54%--

Revenue Forecast

$2B $3B $3B $4B $4B $5B Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27
Reported$2.23B$2.54B$2.74B$3.11B$3.31B--
Avg Forecast$2.24B$2.52B$2.75B$3.08B$3.39B$3.70B$4.12B
High Forecast$2.26B$2.55B$2.79B$3.12B$3.44B$3.70B$4.18B
Low Forecast$2.22B$2.50B$2.72B$3.07B$3.36B$3.70B$4.08B
Surprise %-0.59%0.75%-0.24%1.19%-2.31%--

Net Income Forecast

$-200M $-110M $-20M $70M $160M $250M Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27
Reported$-70.90M$-54.60M$-11.90M$-168.10M$-77.90M--
Avg Forecast$-86.91M$-58.15M$-11.90M$109.27M$118.76M$134.00M$220.40M
High Forecast$-69.53M$-42.53M$-8.70M$123.37M$147.04M$169.40M$223.98M
Low Forecast$-104.29M$-73.77M$-15.10M$95.17M$90.48M$118.74M$216.82M
Surprise %-18.42%-6.10%--253.84%-165.60%--

SGRY Forecast FAQ

Is Surgery Partners stock a buy?

Surgery Partners stock has a consensus rating of Buy, based on 22 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 14 Buy, 8 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Surgery Partners is a favorable investment for most analysts.

What is Surgery Partners's price target?

Surgery Partners's price target, set by 22 Wall Street analysts, averages $18.85 over the next 12 months. The price target range spans from $16.25 at the low end to $21 at the high end, suggesting a potential 39.84% change from the previous closing price of $13.48.

How does Surgery Partners stock forecast compare to its benchmarks?

Surgery Partners's stock forecast shows a 39.84% upside, outperforming the average forecast for the healthcare stocks sector (15.45%) and outperforming the medical care facilities stocks industry (19.55%).

What is the breakdown of analyst ratings for Surgery Partners over the past three months?

  • March 2026: 8.33% Strong Buy, 66.67% Buy, 25.00% Hold, 0% Sell, 0% Strong Sell.
  • February 2026: 8.33% Strong Buy, 66.67% Buy, 25.00% Hold, 0% Sell, 0% Strong Sell.
  • January 2026: 8.33% Strong Buy, 66.67% Buy, 25.00% Hold, 0% Sell, 0% Strong Sell.

What is Surgery Partners’s EPS forecast?

Surgery Partners's average annual EPS forecast for its fiscal year ending in December 2026 is $1.21, marking a -298.36% decrease from the reported $-0.61 in 2025. Estimates for the following years are.

What is Surgery Partners’s revenue forecast?

Surgery Partners's average annual revenue forecast for its fiscal year ending in December 2026 is $3.7B, reflecting a 11.85% increase from the reported $3.31B in 2025. The forecast for.

What is Surgery Partners’s net income forecast?

Surgery Partners's net income forecast for the fiscal year ending in December 2026 stands at $134M, representing a -272.02% decrease from the reported $-77.9M in 2025. Projections indicate .